>
NEW PAPER REVEALS HOW ANONYMOUS AGENTS ERASE YEARS OF VACCINE SAFETY AND...
72 Straight Hours Of Major Outages Doesn't Seem Like A "Coincidence" To Me
Strategy And The Endless Reinvention Of Nothing
Inside the 007 casting, including the mistake that cleared the way for Robert Pattinson...
SpaceX Just Caught Starship on Its FIRST Attempt!
Solid-State Cells Can Make The U.S. Competitive In Batteries Again: CEO
Jetson ONE personal eVTOL pod is about to go full sky patrol
America's INSANE BREAKTHROUGH Could Replace Septic Tanks Forever
Amazing DIY Building Material for Home & Yard - Inexpensive and Easy!
Researchers have discovered a massive deposit of hidden water...
Amazon's Ring Unveils Flying Drone And Robot To Patrol Homes And Businesses
Anthropic Strikes $3.4 Billion Off-Grid Power Agreement to Bypass U.S. Grids, Reports Say
The X-ray room just shrank to the size of a laptop
Gritt and MasTec partner to bring physical AI to solar construction sites

Preclinical evidence suggests that short-term fasting and diets that mimic fasting can protect healthy cells against chemotherapy, while simultaneously rendering cancer cells more vulnerable to the treatment. However, clinical research evaluating the potential of short-term fasting in patients with cancer is still in its infancy.
This was shown in a new paper published last week in Nature: Communications by Dutch scientists from Leiden who looked at fasting-mimicking diets in patients undergoing chemotherapy for the most common form of breast cancer.
In the trial conducted by Dr. Judith Kroep and colleagues, 129 patients with HER2-negative stage II/III breast cancer followed either a fasting-mimicking diet or their regular diet for 3 days prior to and during neoadjuvant chemotherapy (treatment given as a first step to shrink a tumor before surgery).